Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Slupe, A.; Williams, B.; Larson, C.; Lee, L.M.; Primbs, T.; Bruesch, A.J.; Bjorklund, C.; Warner, D.L.; Peloquin, J.; Shadle, S.E.; Gambliel, H.A.; Cusack, B.J.; Olson, R.D.; Charlier, H.A.
    Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase (2005), Cardiovasc. Toxicol., 5, 365-376.
    View publication on PubMed

Cloned(Commentary)

EC Number Cloned (Comment) Organism
1.1.1.184 expression in Escherichia coli strain BL21(DE3) Homo sapiens

Inhibitors

EC Number Inhibitors Comment Organism Structure
1.1.1.184 rutin
-
 Homo sapiens

KM Value [mM]

EC Number KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
1.1.1.184 additional information
-
 additional information recombinant enzyme, steady-state kinetics, molecular modeling and substrate docking studies Homo sapiens

Natural Substrates/ Products (Substrates)

EC Number Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
1.1.1.184 daunorubicin + NADPH + H+ Homo sapiens reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties daunorubicinol + NADP+
-
 ?
1.1.1.184 doxorubicin + NADPH + H+ Homo sapiens reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties doxorubicinol + NADP+
-
 ?
1.1.1.184 menadione + NADPH + H+ Homo sapiens reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties ?
-
 ?
1.1.1.184 mitroxantrone + NADPH + H+ Homo sapiens reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties ?
-
 ?
1.1.1.184 naphthazarin + NADPH + H+ Homo sapiens reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties ?
-
 ?

Organism

EC Number Organism UniProt Comment Textmining
1.1.1.184 Homo sapiens P16152
-
-

Purification (Commentary)

EC Number Purification (Comment) Organism
1.1.1.184 recombinant enzyme from Escherichia coli strain BL21(DE3) by anion exchange chromatography Homo sapiens

Reaction

EC Number Reaction Comment Organism Reaction ID
1.1.1.184 R-CHOH-R' + NADP+ = R-CO-R' + NADPH + H+ molecular modeling and enzyme-substrate docking studies, reaction mechanism with anthracyclin substrates Homo sapiens
a

Source Tissue

EC Number Source Tissue Comment Organism Textmining
1.1.1.184 liver
-
 Homo sapiens
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
1.1.1.184 13-deoxydoxorubicin + NADPH + H+ an anthracyclin, formation of a 13-hydroxy-anthracyclin Homo sapiens ?
-
 ?
1.1.1.184 daunorubicin + NADPH + H+ reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties Homo sapiens daunorubicinol + NADP+
-
 ?
1.1.1.184 daunorubicin + NADPH + H+ an anthracyclin, formation of a 13-hydroxy-anthracyclin Homo sapiens daunorubicinol + NADP+
-
 ?
1.1.1.184 doxorubicin + NADPH + H+ reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties Homo sapiens doxorubicinol + NADP+
-
 ?
1.1.1.184 doxorubicin + NADPH + H+ an anthracyclin, formation of a 13-hydroxy-anthracyclin Homo sapiens doxorubicinol + NADP+
-
 ?
1.1.1.184 menadione + NADPH + H+ reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties Homo sapiens ?
-
 ?
1.1.1.184 menadione + NADPH + H+ an anthracyclin, formation of a 13-hydroxy-anthracyclin Homo sapiens ?
-
 ?
1.1.1.184 mitroxantrone + NADPH + H+ reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties Homo sapiens ?
-
 ?
1.1.1.184 mitroxantrone + NADPH + H+ an anthracyclin, formation of a 13-hydroxy-anthracyclin Homo sapiens ?
-
 ?
1.1.1.184 naphthazarin + NADPH + H+ reduction of the anthracycline C13 carbonyl results in a 13-hydroxy metabolite that elicits potent cardiotoxic effects while possessing significantly reduced anticancer properties Homo sapiens ?
-
 ?
1.1.1.184 naphthazarin + NADPH + H+ an anthracyclin, formation of a 13-hydroxy-anthracyclin Homo sapiens ?
-
 ?

Subunits

EC Number Subunits Comment Organism
1.1.1.184 More molecular modeling and generation of a three-dimensional structural model Homo sapiens

Synonyms

EC Number Synonyms Comment Organism
1.1.1.184 carbonyl reductase 1
-
 Homo sapiens
1.1.1.184 CBR1
-
 Homo sapiens

Temperature Optimum [°C]

EC Number Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
1.1.1.184 25
-
 assay at Homo sapiens

pH Optimum

EC Number pH Optimum Minimum pH Optimum Maximum Comment Organism
1.1.1.184 7.5
-
 assay at Homo sapiens

Cofactor

EC Number Cofactor Comment Organism Structure
1.1.1.184 NADPH dependent on Homo sapiens